ASCLETIS-B(01672.HK)

Event Tracking

Jan5

Ascletis Pharma Receives FDA Approval for ASC30 Phase II Clinical Trial for Type 2 Diabetes

00:01

Dec29

Galore Pharmaceuticals-B Repurchased 200,000 Shares

10:24

East China Securities Gives Buy Rating to Ascletis-B

02:40

Dec22

Galore Pharmaceuticals-B Repurchased 200,000 Shares for HKD 2.4937 Million

09:56

Dec18

GALLEON BIOSCIENCES REPUCHASES 200,000 SHARES FOR HKD2.54 MILLION

11:59

Dec16

Ascletis Pharma Increases Share Repurchase Funds to HKD 500 Million

09:02

Schedules & Filings

Schedules

Filings

Aug15

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 591.59 K, Net Income -48.13 M, EPS -0.05

Gere Pharmaceutical (1672.HK) 2025 Mid-Year Performance Conference Call

Mar26

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 682.46 K, Net Income -90.76 M, EPS -0.0919

Aug30

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -70.02 M, EPS -0.0688

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change